Furthermore, we performed in vitro validation of IQ efficacy using RT-PCR and qRT-PCR assays and confirmed that IQ can trigger PTGS2, PIK3CA, and IGF1R gene targets to control kidney cancer and inflammation. Here, PTGS2 is linked to kidney cancer.